Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Several phase 3 trials evaluating retatrutide are expected to complete in 2026, and Lilly plans to submit retatrutide by the end of 2026 based on the TRIUMPH trials in obesity, a Lilly spokesperson told Everyday Health
View this as a two-year journey that lays the groundwork for lasting change in your life. Dr
The goal is reaching your target maintenance dose eventually, not reaching it on a rigid timeline
Maximum weight loss: 24.2% at 12 mg/week (Jastreboff et al., 2023)
Metabolic and Cardiovascular Benefits Weight loss medications often deliver benefits beyond the scale
As the newest weight-loss drug on the scene, retatrutide targets three receptors: GLP-1, GIP and glucagon
US$ 22.63
US$ 25.58
US$ 25.86
US$ 21.95
